Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition

NCT01589562 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Megace 800mg/20ml
DRUG: DW-ES(B) 625mg/5ml

Sponsor

Daewon Pharmaceutical Co., Ltd.

Collaborators

[object Object]